Evaluating and improving diagnostics and management of venous thromboembolism
VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism
This study is trying to find better ways to diagnose and manage blood clots in the veins for older patients who might have deep vein thrombosis or pulmonary embolism.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Johannes Gutenberg University Mainz Academic / other |
| Locations | 1 site (Mainz, Rhineland-Palatinate) |
| Trial ID | NCT02156401 on ClinicalTrials.gov |
What this trial studies
The VTEval Project is a prospective observational study aimed at evaluating and improving the diagnostics and management strategies for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). It involves three long-term cohorts of patients with suspected or incident VTE, focusing on systematic assessments of disease status and risk profiles. The study seeks to address the significant public health challenges posed by VTE, particularly in older populations, by collecting comprehensive data on symptoms, clinical factors, and psychosocial aspects.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with clinical suspicion of acute PE, acute DVT, or incidentally diagnosed VTE.
Not a fit: Patients who do not have clinical suspicion of VTE or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and management strategies for patients with venous thromboembolism, potentially reducing morbidity and mortality associated with the condition.
How similar studies have performed: Other studies have shown success in improving VTE management and diagnostics, indicating that this approach has potential based on previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years and Informed written consent * Clinical condition: * Cohort 1: Clinical suspicion of acute PE (with or without DVT) * Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE) * Cohort 3: Incidentally diagnosed VTE
Where this trial is running
Mainz, Rhineland-Palatinate
- University Medical Center of the Johannes Gutenberg University Mainz — Mainz, Rhineland-Palatinate, Germany (Recruiting)
Study contacts
- Principal investigator: Philipp S Wild, MD, MSc — University Medical Center of Johannes Gutenberg University Mainz, Germany
- Study coordinator: Philipp S Wild, MD, MSc
- Email: philipp.wild@unimedizin-mainz.de
- Phone: 0049 6131 17 7163
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.